PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1290476
PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1290476
Global Portable Mass Spectrometers Market is valued at approximately USD 2,025.52 million in 2022 and is anticipated to grow with a healthy growth rate of more than 9.1% over the forecast period 2023-2030. A portable Mass Spectrometer is an analytical instrument for research that is used to calculate the exact molecular weight of the sample components and measures the fluctuation in a physical property across a specified range or spectrum. Portable Mass Spectrometers are used in various industries such as science, Nanotechnology, and food & beverage. The increasing demand for Portable Mass Spectrometers in pharmaceutical and biomedical R&D is the key factor responsible for the market growth over the forecast period of 2023-2030.
The primary key factor anticipated to accelerate the growth of the Portable Mass Spectrometers Market is the increasing demand in the pharmaceutical industry. According to the "European Federation of Pharmaceutical Industries and Association", In 2021, North America accounted for 49.1% of world pharmaceutical sales compared with 23.4% for Europe. and in 2020 the pharmaceutical industry invested more than EUR 39,600 million in R&D in Europe. Also, the various product launches by key players are creating a lucrative growth prospectus for the market over the forecast period. Moreover, technological advancements such as smartphone spectrometers and increasing investment by government and private organizations create a positive outlook for the market. However, the limited range of tests and sensitivity of portable spectrometer devices stifles market growth throughout the forecast period of 2023-2030.
The key regions considered for the Global Portable Mass Spectrometers Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in terms of revenue owing to factors such as growing investments by the government in research & development of the biomedical and pharmaceuticals industry. The U.S. and Canada are major key contributors to the growth of the market. Asia-Pacific is the fastest-growing region due to the rising adoption of stringent regulatory guidelines for drug testing and the increasing usage of illicit drugs.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
List of figures
List of tables and figures and dummy in nature, final lists may vary in the final deliverable